Home ProductsAmino Acids

Pharmaceutical 1.084g/Cm3 CAS 83435-58-9 Boc-D-Prolinol

Pharmaceutical 1.084g/Cm3 CAS 83435-58-9 Boc-D-Prolinol

  • Pharmaceutical 1.084g/Cm3 CAS 83435-58-9 Boc-D-Prolinol
Pharmaceutical 1.084g/Cm3 CAS 83435-58-9 Boc-D-Prolinol
Product Details:
Place of Origin: Made in China
Brand Name: Zhihua
Model Number: Handmade
Payment & Shipping Terms:
Minimum Order Quantity: 1 Piece
Price: To be negotiated
Packaging Details: 1KGS/Carton
Delivery Time: 3-20Days
Payment Terms: L/C, D/A, D/P, T/T, Western Union, MoneyGram
Supply Ability: 1000Ton/Month
Contact Now
Detailed Product Description
Product Name: Boc-D-prolinol CAS: 83435-58-9
Molecular Formula: C10H19NO3 Molecular Weight: 201.26
Application(s): Peptide Synthesis: Suitable Boiling Point: 289.5±13.0 °C(Predicted)
Density : 1.084±0.06 G/cm3(Predicted) Form: Crystalline Powder
High Light:

Pharmaceutical CAS 83435-58-9


1.084g/cm3 CAS 83435-58-9


Pharmaceutical Boc-D-Prolinol

CAS 83435-58-9 Boc-D-Prolinol


  • Melting point: :60-64 °C(lit.)
  • alpha :49 º (589nm, =1.3, CHCl3)
  • Boiling point: :289.5±13.0 °C(Predicted)
  • Density :1.084±0.06 g/cm3(Predicted)
  • refractive index :54 ° (C=5, MeOH)
  • storage temp. :Store at 0°C
  • form :Crystalline Powder
  • pka :14.77±0.10(Predicted)
  • color :White to light beige
  • optical activity :[α]23/D +50°, c = 1.3 in chloroform
  • Water Solubility :insoluble
Name High quality Boc-D-prolinol cas 83435-58-9 with best price
Other name (R)-(+)-1-(tert-Butoxycarbonyl)-2-pyrrolidinemethanol;N-Boc-D-prolinol;N-(tert-Butoxycarbonyl)-D-prolinol;N-t-BOC-D-Prolinol;
CAS 83435-58-9
Applications Organic intermediate; Intermediates of pyrotinib
Appearance White Powder


Product name
Molecular formula
Molecular weight
Purity 99%
Appearance White powder
EINECS number


Boc-D-prolinol CAS 83435-58-9 is white powder. It is an organic intermediate compound. It is an important intermediate of pyrotinib. Pyrotinib is a novel irreversible epidermal growth factor receptor/HER2 dual tyrosine kinase inhibitor.


Pyrotinib is an irreversible dual pan-ErbB receptor tyrosine kinase inhibitor developed for the treatment of HER2-positive advanced solid tumours. Based on positive results in a phase II trial, the drug recently received conditional approval in China for use in combination with capecitabine for the treatment of HER2-positive, advanced or metastatic breast cancer in patients previously treated with anthracycline or taxane chemotherapy.

Boc-D-prolinol CAS 83435-58-9 could be supplied in commercial size with competitive price.


Contact Details
Shanghai Zhihua ChemTech Co. Ltd.

Contact Person: Xiaojun Ji

Tel: 086-13774313779

Send your inquiry directly to us
Other Products